Role of Helicobacter pylori in gastritis, gastric ulcer and gastric carcinogenesis

Japanese Journal of Gastroenterology

Volumn 99, Issue 11, 2002, Pages 1303-1311

  Kodama, Masaaki ^a   Sato, Ryugo ^b   Murakami, Kazunari ^a   Fujioka, Toshio ^a  

^a OITA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL STRAIN; GASTRITIS; HELICOBACTER PYLORI; HUMAN; STOMACH CARCINOGENESIS; STOMACH ULCER;

GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS; STOMACH ULCER;

EID: 0036858166     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Marschall BJ, Armstrong JA: Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436-439
2. Morris A, Nicholson G: Ingestion of Campylobacter pyloridis causes gastritis and raised fasting pH. Am J Gastroenterol 1987; 82: 192-199
3. Czinn SJ, Dahms BB, Jacobs GH, et al: Campylobacter-like organisms in association with symptomatic gastritis in children. J Pediatr 1986; 109: 80-83
4. Eastham EJ, Elliott TS, Berkeley D, et al: Campylobacter pylori infection in children. J Infect 1988; 16: 77-79
5. Kimura K: Chronological transition of the fundicpyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972; 63: 584-592
6. Ihamaki Y, Kekki M, Sipponen P, et al: The sequelae and course of chronic gastritis during a 33 to 34-year bioptic follow-up study. Scand J Gastroenterol 1985; 20: 485-491
7. Kuipers EJ, Uyterlinde AM, Pena AS, et al: Long term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-1528
8. Valle J, Kekki M, Sipponen P, et al: Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996; 31: 546-550
9. Satoh K, Kimura K, Taniguchi Y, et al: Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and-negative patients with chronic gastritis. Am J Gastroenterol 1996; 91: 963-969
10. Sipponen P, Hyvarinen H, Siurala M: H. pylori corpus gastritis - Relation to acid output. J Physiol Pharmacol 1996; 47: 151-159
11. Covacci A, Censini S, Bugnoli M, et al: Molecular characterization of the 128 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5795
12. Cover TL, Tummuru MK, Cao P, et al: Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269: 10566-10573
13. Censini S, Lange C, Xiang Z, et al: Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 1996; 93: 14648-14653
14. Covacci A, Telford JL, Giudice GD, et al: Helicobacter pylori virulence and genetic geography. Science 1999; 284: 1328-1333
15. Odenbreit S, Puls J, Sedlmaier B, et al: Translocation of Helicobacter pylori cag A into gastric epithelial cells by type IV secration. Science 2000; 287: 1497-1500
16. Sande N, Nikulin M, Nilsson I, et al: Increased risk of developing atrophic gastritis in patients infected with CagA + Helicobacter pylori. Scand J Gastroenterol 2001; 36: 928-933
17. El-Omar EM, Carrington M, Chow WH, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402
18. Calam J, Gibbons A, Healey ZV, et al: How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology. Gastroenterology 1997; 113 (6 Suppl): S43-49
19. Furuta T, El-Omar EM, Xiao F, et al: Interleukin 1 beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123: 92-105
20. Azuma T, Ito S, Sato F, et al: The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 1998; 82: 1013-1018
21. Van Zanten SJ, Dixon MF, Lee A: The gastric transitional zones: Neglected links between gastroduodenal pathology and helicobacter ecology. Gastroenterology 1999; 116: 1217-1229
22. El-Omar EM, Penman ID, Ardill JE, et al: Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-691
23. Levi S, Beardshall K, Haddad G, et al: Campylobacter pylori and duodenal ulcers: The gastrin link. Lancet 1989; 8648: 1167-1168
24. Bloom SR, Mortimer CH, Thorner MO, et al: Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet 1974; 7889: 1106-1109
25. Larsson LI, Goltermann N, de Magistris L, et al: Somatostatin cell processes as pathways for paracrine secretion. Science 1979; 205: 1393-1395
26. Sumii K, Fukushima T, Hirata K, et al: Antral gastrin and somatostatin concentrations in peptic ulcer patients. Peptides 1981; 2 Suppl 2: 281-283
27. Moss SF, Legon S, Bishop AE, et al: Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 8825: 930-932
28. Haruma K, Sumii K, Okamoto S, et al: Helicobacter pylori infection is associated with low antral somatostatin content in young adults. Implications for the pathogenesis of hypergastrinemia. Scand J Gastroenterol 1995; 30: 550-553
29. Kamada T, Haruma K, Kawaguchi H, et al: The association between antral G and D cells and mucosal inflammation, atrophy, and Helicobacter pylori infection in subjects with normal mucosa, chronic gastritis, and duodenal ulcer. Am J Gastroenterol 1998; 93: 748-752
30. Goodwin CS: Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept. Lancet 1988; 8626-8627: 1467-1469
31. Leunk RD, Johnson PT, David BC, et al: Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93-99
32. Atherton JC, Cao P, Peek RM Jr, et al: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 1995; 270: 17771-17777
33. Oi M, Ito Y, Kumagai F, et al: A possible dual control mechanism in the origin of peptic ulcer. A study on ulcer location as affected by mucosa and musculature. Gastroenterology 1969; 57: 280-293
34. Telford JL, Ghiara P, Dell'Orco M, et al: Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653-1658
35. Krakowka S, Eaton KA, Rings DM: Occurence of gastric ulcers in gnotobiotic piglets colonized by Helicobacter pylori. Infect Immun 1995; 63: 2352-2355
36. Marchetti M, Arico B, Burroni D, et al: Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655-1658
37. Kodama R, Fujioka T, Shuto R, et al: Helicobacter pylori infection delays the healing of acetic acid-induced gastric ulcer in Japanese monkeys. J Gastroenterol Hepatol 1996; 11: 1097-1102
38. Honda S, Fujioka T, Tokieda M, et al: Gastric ulcer, atrophic gastritis, and intestinal metaplasia caused by Helicobacter pylori infection in Mongolian gerbils. Scand J Gastroenterol 1998; 33: 454-460
39. Watanabe T, Tada M, Nagai H, et al: Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115: 642-648
40. Warburton VJ, Everett S, Mapstone NP, et al: Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol 1998; 51: 55-61
41. Lehmann FS, Golodner EH, Wang J, et al: Mononuclear cells and cytokines stimulate gastrin release from canine antral cells in primary culture. Am J Physiol 1996; 270: G783-G788
42. Beales IL, Calam J: Helicobacter pylori infection and tumour necrosis factor-alpha increase gastrin release from human gastric antral fragments. Eur J Gastroenterol Hepatol 1997; 9: 773-777
43. Houghton J, Macera-Bloch LS, Harrison L, et al: Tumor necrosis factor alpha and interleukin 1 beta up-regulate gastric mucosal Fas antigen expression in Helicobacter pylori infection. Infect Immun 2000; 68: 1189-1195
44. Lanas A, Garcia-Gonzalez MA, Santolaria S, et al: TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients. Genes Immun 2001; 2: 415-421
45. Correa P: Human gastric carcinogenesis: A multistep and multifactorial process-first american cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735-6740
46. Calam J, Baron JH: ABC of the upper gastrointestinal tract: Pathophysiology of duodenal and gastric ulcer and gastric cancer. BMJ 2001; 323: 980-982
47. Forman D, Newell DG, Fullerton F, et al: Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991; 302: 1302-1305
48. Parsonnet J, Friedman GD, Vandersteen DP, et al: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131
49. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-1362
50. Nomura A, Stemmermann GN, Chyou PH, et al: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-1136
51. Schistosomes, Liver Flukes and Heliicobacter Pylori. IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 7-14. June, 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1994; 61: 1-241
52. Schistosomes, liver flukes and Heliicobacter pylori. IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 7-14. June, 1994. IARC monographs on the evaluation of carcinogenic risks to humans 1994; 61: 1-241
53. Huang JQ, Sridhar S, Chen Y, et al: Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer: Gastroenterology 1998; 114: 1169-1179
54. Fujioka T, Shuto R, Kodama R, et al: Experimental model for chronic gastritis with Helicobacter pylori: Long term follow-up study in H. pylori-infected Japanese macaques. Eur J Gastroenterol Hepatol 1993; 5 (supple 1): s73-s77
55. Kodama M, Fujioka T, Kodama R, et al: p53 expression in gastric mucosa with Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 215-219
56. Oda T, Murakami K, Nishizono A, et al: Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene. Helicobacter 2002; 7: 143-151
57. Honda S, Fujioka T, Tokieda M, et al: Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-4259
58. Correa P: Human gastric carcinogenesis: A multistep and multifactorial process-first american cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735-6740
59. Lauwers GY, Wahl SJ, Melamed J, et al: p53 expression in precancerous gastric lesions: An immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol 1993; 88: 1916-1919
60. Correa P, Shiao YH: Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994; 54 (suppl): 1941s-1943s
61. Tahara E, Kuniyasu H, Yasui W, et al: Gene alterations in intestinal metaplasia and gastric cancer. Eur J Gastroenterol Hepatol 1994; 6 (suppl 1): S97-S101
62. Shiao YH, Rugge M, Correa P, et al: p53 alteration in gastric precancerous lesions. Am J Pathol 1994; 144: 511-517
63. Murakami K, Fujioka T, Okimoto T, et al: Analysis of p53 gene mutation in Helicobacter pylori-associated gastritis mucosa in endoscopic biopsy specimens. Scand J Gastroenterol 1999; 34: 474-477
64. Kikuchi S, Wada O, Nakajima T, et al: Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults, Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer 1995; 75: 2789-2793
65. Uemura N, Okamoto S, Yamamoto S, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789